Clinical Chemistry
27 March 2019
Suntec Singapore
Key topics:
- Advances in mass spectrometry
- Unusual thyroid function tests
- Old and new biomarkers for kidney disease
- Stroke biomarkers discovery
- Parathyroid Hormone Measurement
Benefits of attending:
- Identify latest updates in assays
- Appraise use of biomarkers in clinical laboratory
- Review diagnostic and prognostic biomarkers for kidney
- Discuss glycation markers in diabetes
09:50
Opening remarks
Dr Leslie Lam, Director (Chemical Pathology) & Senior Consultant, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore
Session 1
10:00
More unusual thyroid function tests
A/Prof Chris Florkowski, Associate Professor, Canterbury Health Laboratories, Christchurch, New Zealand
10:30
Parathyroid Hormone Measurement in Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD)
Dr Leslie Lam, Director (Chemical Pathology) & Senior Consultant, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore
11:00
The role of bone markers in investigation and management of metabolic bone disease
Dr Samuel Vasikaran, Consultant Chemical Pathologist, PathWest - Fiona Stanley and Royal Perth Hospitals, Perth, Australia
11:30
Q&A
11:45
Lunch break and visit exhibition
Session 2
13:00
Clinical case interpretation
Dr Wong Moh Sim, Head & Sr Consultant, Dept of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore
13:30
The role of moving patient means in quality assurance
Dr Tony Badrick, Chief Executive, The Royal College of Pathologists of Australasia - Quality Assurance Programs (RCPAQAP), New South Wales, Australia
14:00
Glycation markers in diabetes
Dr Joris R Delanghe, Professor, Clinical Chemistry, Ghent University, Gent, Belgium
14:30
Q&A
14:45
Coffee Break
Session 3
15:15
Implementing mass spectrometry in the clinical laboratory
Jayme Wong, Senior Principal Medical Laboratory Scientist, Department of Clinical Pathology, Singapore General Hospital, Singapore
15:45
Measurement uncertainty
Dr Tony Badrick, Chief Executive, The Royal College of Pathologists of Australasia - Quality Assurance Programs (RCPAQAP), New South Wales, Australia
16:15
New biomarkers for management of acute heart failure
Prof Salvatore Di Somma, President, GREAT Network; Professor of Medicine, Chairman and Director Emergency Medicine, Sapienza University of Rome, Rome, Italy
16:45
Q&A
17:00
End of conference
Conference Chairs:
Dr Leslie Lam, Director (Chemical Pathology) & Senior Consultant, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore
A/Prof Chris Florkowski, Associate Professor, Canterbury Health Laboratories, Christchurch, New Zealand
Speaker Faculty:
Jayme Wong, Senior Principal Medical Laboratory Scientist, Department of Clinical Pathology, Singapore General Hospital, Singapore
Dr Joris R Delanghe, Professor, Clinical Chemistry, Ghent University, Gent, Belgium
Prof Salvatore Di Somma, President, GREAT Network; Professor of Medicine, Chairman and Director Emergency Medicine, Sapienza University of Rome, Rome, Italy
Dr Samuel Vasikaran, Consultant Chemical Pathologist, PathWest - Fiona Stanley and Royal Perth Hospitals, Perth, Australia
Dr Tony Badrick, Chief Executive, The Royal College of Pathologists of Australasia - Quality Assurance Programs (RCPAQAP), New South Wales, Australia
Dr Wong Moh Sim, Head & Sr Consultant, Dept of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore
.png)
